Literature DB >> 19473876

Hepatitis B viral markers in banked human milk before and after Holder pasteurization.

Patricia Ribeiro de Oliveira1, Aparecida Yulie Yamamoto, Cleonice Barbosa Sandoval de Souza, Natalia Motta de Araújo, Selma de Andrade Gomes, Anália Ribeiro Heck, José Fernando de Castro Figueiredo, Marisa Márcia Mussi-Pinhata.   

Abstract

BACKGROUND: Blood screening for hepatitis B virus (HBV) is not universally performed for donor selection in human milk banks.
OBJECTIVES: To evaluate the frequency of detection of HBV surface antigen (HBsAg) and HBV-DNA in colostrum of HBV-infected nursing mothers before and after Holder pasteurization. STUDY
DESIGN: Forty-two concentrated breast milk samples were obtained within two postnatal weeks from 24 HBsAg-positive women (4 HBeAg-positive and 20 HBeAg-negative, anti-HBe-positive) were tested for the presence of HBsAg and HBV-DNA before and after Holder pasteurization (30min at 62.5 degrees C).
RESULTS: Before pasteurization, HBsAg and HBV-DNA were found in 14/24 (58%), and 20/24 (75%) first milk samples, respectively, obtained by 4 days after delivery. At least one marker was detected in 20/24 (83%) milk samples. Both markers were identified in milk of HBeAg-positive mothers, and most mothers with anti-HBe in blood had at least one HBV marker. Once detected, viral markers were frequently found in milk samples subsequently obtained from the same woman. Holder pasteurization did not affect the probability of detecting HBsAg (8/18, 44%), HBV-DNA (12/18, 67%), or at least one of them (15/18, 83%).
CONCLUSIONS: Although the biological implications of these findings remain to be determined, considering that HBV is highly contagious and most recipients of banked human milk are preterm infants, these findings should be taken into account when donors are enlisted for human milk banks without serological screening.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473876     DOI: 10.1016/j.jcv.2009.04.003

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  7 in total

Review 1.  Breastfeeding and chronic HBV infection: clinical and social implications.

Authors:  Mihaela Petrova; Victor Kamburov
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

2.  Inhibition of In Vitro Infection of Hepatitis B Virus by Human Breastmilk.

Authors:  Yuqian Luo; Kuanhui Xiang; Jingli Liu; Ji Song; Jing Feng; Jie Chen; Yimin Dai; Yali Hu; Hui Zhuang; Yihua Zhou
Journal:  Nutrients       Date:  2022-04-08       Impact factor: 6.706

3.  Determination of Dornic acidity as a method to select donor milk in a milk bank.

Authors:  Sara Vázquez-Román; Nadia Raquel Garcia-Lara; Diana Escuder-Vieco; Fernando Chaves-Sánchez; Javier De la Cruz-Bertolo; Carmen Rosa Pallas-Alonso
Journal:  Breastfeed Med       Date:  2012-06-25       Impact factor: 1.817

4.  High Level of HBV DNA Virus in the Breast Milk Seems not to Contraindicate Breastfeeding.

Authors:  A Montoya-Ferrer; A M Zorrilla; J Viljoen; J P Molès; M L Newell; P Van de Perre; E Tuaillon
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-07-01       Impact factor: 2.576

5.  Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus.

Authors:  Xiangru Chen; Jie Chen; Jian Wen; Chenyu Xu; Shu Zhang; Yi-Hua Zhou; Yali Hu
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

Review 6.  Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy.

Authors:  Stephanie Pfaender; Thomas von Hahn; Joerg Steinmann; Sandra Ciesek; Eike Steinmann
Journal:  Rev Med Virol       Date:  2016-05-17       Impact factor: 6.989

7.  Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study.

Authors:  Jihyun An; Jong Woo Kim; Ju Hyun Shim; Seungbong Han; Chang Sik Yu; Jaewon Choe; Danbi Lee; Kang Mo Kim; Young-Suk Lim; Young-Hwa Chung; Yung Sang Lee; Dong Jin Suh; Jin Hyoung Kim; Han Chu Lee
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.